Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.02 (+0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Artelo Biosciences (ARTL) Other Accumulated Expenses (2015 - 2026)

Updated

Analysis

Artelo Biosciences (ARTL) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Artelo Biosciences 49.32 Mn 32.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 111,000.00
Mar 31, 2026 468,000.00
Dec 31, 2025 345,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 23,000.00
Dec 31, 2024 61,000.00
Sep 30, 2024 36,000.00
Jun 30, 2024 44,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 30,000.00
Sep 30, 2023 49,000.00
Jun 30, 2023 46,000.00
Mar 31, 2023 87,000.00
Dec 31, 2022 53,000.00
Sep 30, 2022 27,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 43,000.00
Nov 30, 2021 38,000.00
Aug 31, 2021 27,000.00
API Access

Artelo Biosciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ARTL&period=max&api_key=YOUR_API_KEY